Role of histamine in the pathophysiology of asthma: Immunomodulatory and anti-inflammatory activities of H1-receptor antagonists

American Journal of Medicine

Volumn 113, Issue 9 SUPPL. 1, 2002, Pages 2-7

  Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CLEMASTINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; METHACHOLINE; MONTELUKAST; PSEUDOEPHEDRINE; TERFENADINE;

AIRWAY INFLAMMATION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; CLINICAL TRIAL; DISEASE MODEL; DOSE CALCULATION; DRUG INDICATION; DRUG MEGADOSE; DRUG TARGETING; HUMAN; IMMUNOMODULATION; MEDIATOR; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SEDATION;

EID: 0037122432     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(02)01431-6     Document Type: Review

References (70)

1. White M.V. The role of histamine in allergic disease. J Allergy Clin Immunol. 86:1990;599-605.
2. White M.V., Slater J.E., Kaliner M.A. Histamine and asthma. Am Rev Respir Dis. 135:1987;1165-1176.
3. 1) receptor radioligand and binding studies on normal T cell subsets, B cells, and monocytes. J Immunol. 136:1986;2116-2120.
4. 2 histamine receptors. Immunology. 41:1980;107-114.
5. Jeanin P., Delneste Y., Gosset P., et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood. 84:1994;2229-2233.
6. Abedelaziz M.M., Devalia J.L., Khair O.A., et al. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 101:1998;410-420.
7. Bachert C. Histamine a major role in allergy? Clin Exp Allergy. 28:1998;15-19.
8. Miki I., Kusano S., Ohta N., et al. Histamine enhanced the TNF-α-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol. 171:1996;285-288.
9. 1 receptor. Proc Natl Acad Sci U S A. 88:1991;11515-11519.
10. 1 receptors in guinea-pig brain. J Neurochem. 31:1978;997-1004.
11. 1 receptors on human peripheral lung. Biochem Pharmacol. 34:1982;3285-3292.
12. 3H] mepyramine binding in porcine tracheal tissue. Eur J Pharmacol. 139:1987;287-295.
13. 3H] mepyramine binding to the longitudinal muscle of guinea-pig small intestine. Mol Pharmacol. 19:1981;379-387.
14. 1 receptors in guinea-pig urinary bladder. Eur J Pharmacol. 114:1985;89-92.
15. 1 receptor in endothelial and smooth muscle cells of guinea-pig aorta. Eur J Pharmacol. 148:1988;161-169.
16. 1 receptors on CD8 T lymphocytes. J Immunol. 144:1990;1449-1459.
17. Ash A.S.F., Schlid H.O. Receptors mediating some actions of histamine. Br J Pharmacol. 27:1966;427-439.
18. Larsen J.S. Do antihistamines have a role in asthma therapy? Pharmacotherapy. 21:2001;28S-33S.
19. 2 receptors. Nature. 236:1972;385-390.
20. 3) of histamine receptor. Nature. 302:1983;832-837.
21. 4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther. 299:2001;121-130.
22. Casolaro V., Galeone D., Giacummo A., et al. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis. 139:1989;1375-1382.
23. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis. 142:1990;126-132.
24. Wenzel S.E., Fowler A.A., Schwartz L.B. Activation of pulmonary mast cells by bronchoalveolar allergen challenge in vivo release of histamine and tryptase in atopic subjects with and without asthma . Am Rev Respir Dis. 137:1988;1002-1008.
25. Crimi E., Chiaramondia M., Milanese M., et al. Increase of mast cell numbers in mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis. 144:1991;1282-1286.
26. Pesci A., Foresi A., Bertorelli G., et al. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis. 147:1993;684-689.
27. Jarjour N.N., Calhoun W.J., Schwartz L.B., Busse W.W. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis. 144:1991;83-87.
28. Simons FER, Simons KJ. Antihistamines. In: Middleton F Jr, Reed CE, Ellis EF, et al, eds. Allergy: Principles and Practice, 4th ed. St. Louis, MO: Mosby Year Book, 1993:856-878.
29. 1 receptors. J Immunol. 166:2001;4083-4091.
30. Caron G., Delneste Y., Roelandts E., et al. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol. 166:2001;6000-6006.
31. Paolieri F., Battifora M., Riccio A.M., et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol. 81:1998;601-607.
32. Malick A., Grant J.A. Antihistamines in the treatment of asthma. Allergy. 52:1997;55-66.
33. 1-receptor antagonists, clemastine and chlorpheniramine in wheezy school children. Br J Dis Chest. 77:1993;270-275.
34. Nogrady S.G., Hartley J.P., Handslip P.D., Hurst N.P. Bronchodilation after inhalation of the antihistamine clemastine. Thorax. 33:1978;479-482.
35. 1 blocker, chlorpheniramine. J Allergy Clin Immunol. 55:1977;54-63.
36. 1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol. 91:1993;1005-1014.
37. MacFarlane P.I., Heaf D.P. Selective histamine blockade in childhood asthma the effect of terfenadine on resting bronchial tone and exercise induced bronchoconstriction . Respir Med. 83:1989;19-24.
38. Patel K.R., Ghosh S.K., Matcham J. Lack of dose-response effect of terfenadine on resting bronchomotor tone in patients with asthma. Clin Exp Allergy. 21:1991;363-366.
39. Spector S.L., Nicodemus C.F., Corren J., et al. Comparison of the bronchodilatory effects of cetirizine, albuterol and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol. 96:1995;174-181.
40. Town G.I., Holgate S.T. Comparison of the effect of loratadine on the airway and skin responses to histamine, methacholine, and allergen in subjects with asthma. J Allergy Clin Immunol. 86:1990;886-893.
41. 1-receptor antagonist on the late asthmatic response to inhaled antigen. Respir Med. 85:1991;393-399.
42. 1-receptor antagonist, terfenadine, on antigen-induced asthma. Br J Dis Chest. 80:1986;375-384.
43. Rafferty P., Beasley R., Holgate S.T. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′-monophosphate in atopic asthma. Am Rev Respir Dis. 136:1987;369-373.
44. Hamid M., Rafferty P., Holgate S.T. The inhibitory effect of terfenadine and flurbiprofen on early and late-phase bronchoconstriction following allergen challenge in atopic asthma. Clin Exp Allergy. 20:1990;261-267.
45. 1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. Thorax. 42:1987;946-952.
46. de Bruin-Weller M.S., Rijssenbeek-Nouwens L.H., de Monchy J.G. Lack of effect of cetirizine on early and late asthmatic response after allergen challenge. J Allergy Clin Immunol. 94:1994;231-239.
47. Ghosh S.K., De Vos C., McIlroy I., Patel K.R. Effect of cetirizine on exercise induced asthma. Thorax. 46:1991;242-244.
48. Clee M.D., Ingram C.G., Reid P.C., Robertson A.S. The effect of astemizole on exercise-induced asthma. Br J Dis Chest. 78:1989;180-183.
49. MacFarlane P.I., Heaf D.P. Selective histamine blockade in childhood asthma the effect of terfenadine on resting bronchial tone and exercise induced bronchoconstriction . Respir Med. 83:1989;19-24.
50. Finnerty J.P., Holgate S.T. The contribution of histamine release and vagal reflexes, alone and in combination, to exercise-induced asthma. Eur Respir J. 6:1993;1132-1137.
51. Finnerty J.P., Holgate S.T. Evidence for the roles of histamine and prostaglandins as mediators in exercise-induced asthma the inhibitory effect of terfenadine and flurbiprofen alone and in combination . Eur Respir J. 3:1990;540-547.
52. Bruttmann G., Pedrali P., Arendt C., Rihoux J.P. Protective effect of cetirizine in patients suffering from pollen asthma. Ann Allergy. 190:1990;224-228.
53. Dijkman J.H., Hekking P.R., Molkenboer J.F., et al. Prophylactic treatment of grass pollen-induced asthma with cetirizine. Clin Exp Allergy. 20:1990;483-490.
54. Bousquet J., Emonot A., Germouty J., et al. Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. Ann Allergy. 65:1990;504-508.
55. Grant J.A., Nicodemus D.F., Findlay S.R., et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma prospective, randomized, placebo-controlled trial . J Allergy Clin Immunol. 95:1995;923-932.
56. Dirksen A., Engel T., Frolung L., et al. Effect of a non-sedative antihistaminic (loratadine) in moderate asthma. A double-blind controlled clinical crossover trial. Allergy. 44:1989;566-571.
57. Ekstrom T., Osterman K., Zetterstrom O. Lack of effect of loratadine on moderate to severe asthma. Ann Allergy Asthma Immunol. 75:1995;287-289.
58. Corren J., Harris A.G., Aaronson D., et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol. 100:1997;781-788.
59. Reicin A., White R., Weinstein S.F., et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med. 160:2000;2481-2488.
60. Taytard A., Beaumont D., Pujet P.C., et al. Treatment of bronchial asthma with terfenadine a randomized controlled trial . Br J Clin Pharmacol. 24:1987;743-746.
61. 1-receptor antagonist in the treatment of grass pollen sensitive asthma. Br J Clin Pharmacol. 30:1990;229-235.
62. 1-receptor antagonist, terfenadine, in chronic severe asthma. Br J Clin Pharmacol. 39:1995;371-375.
63. Kaliner M, Gottlieb G, Lieberman A, et al. Safety of fexofenadine HCl in asthmatic patients requiring inhaled corticosteroids in accordance with NHLBI guidelines. J Allergy Clin Immunol. 2000;105(Pt 2):S388. Abstract 1132.
64. Makela M.J., Kanehiro A., Borish L., et al. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A. 97:2000;6007-6012.
65. Hamelmann E., Schwarze J., Takeda K., et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 156:1997;766-775.
66. Kanehiro A., Ikemura T., Makela M.J., et al. Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med. 163:2001;173-184.
67. Tomkinson A., Kanehiro A., Rabinovitch N., et al. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am J Respir Crit Care Med. 160:1999;1283-1291.
68. Tomkinson A., Cieslewicz G., Duez C., et al. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am J Respir Crit Care Med. 163:2001;721-730.
69. Hamelmann E., Takeda K., Haczku A., et al. Interleukin (IL)-5 but not IgE reconstitutes airway inflammation and airway hyperresponsiveness in IL-4-deficient mice. Am J Respir Cell Mol Biol. 23:2000;327-334.
70. Takeda K., Hamelmann E., Joetham A., et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med. 186:1997;449-454.